| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5885664 | Journal of Critical Care | 2015 | 5 Pages |
Abstract
The use of low-dose rFVIIa (20 μg/kg) is effective for correcting coagulopathy in patients with TBI without an increase in thromboembolic events. Moreover, it is more effective for preventing the occurrence of PHI.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Qiang MD, Xing MD, Zhuo-Ying MD, Yi-Rui PhD, MD, Jian MD, Zhi-Qi MD, Xue-Hai MD, Ying MD, Liang-Fu MD, Jin MD,